** Test Mode **

  0.00 (USD)

This Package provides access to the entire event

REGISTER TODAY!

Built for what’s next: A conversation on what’s next in access, affordability and AI driven patient support ahead of AXS26

Start Date:4/23/2026

Start Time:1:00 PM EDT

Duration:60 minutes

Abstract:

As the industry prepares for Asembia’s AXS26, the specialty pharmacy landscape is experiencing accelerated transformation. Emerging technologies and new approaches to patient and provider engagement are redefining how specialty therapies are delivered and supported.

To help make sense of this rapidly changing environment, the CoverMyMeds’ Innovation Roundtable will bring together leaders from across biopharma services, access technology, policy and patient support. Guests will examine the forces driving change in 2026, share cross‑sector perspectives on where innovation is headed and discuss which emerging capabilities are most likely to influence conversations at Asembia and beyond.

The session will explore themes such as the practical application of AI in patient and provider support, the impact of more interconnected service, and how stakeholders can meaningfully collaborate to improve access and affordability. Designed as a forward‑looking discussion, this roundtable aims to equip attendees with a clearer understanding of the trends shaping the specialty ecosystem, and what innovations will matter most in the year ahead.

If you're already registered for the Built for what’s next: A conversation on what’s next in access, affordability and AI driven patient support ahead of AXS26 webcast, click below:

Register ALREADY REGISTERED?


Speakers

Miranda Delatore, DNP, RN, NEA-BC

Vice President, Product

CoverMyMeds

As an accomplished executive healthcare leader with over 15 years of experience in the industry, Miranda began her career as a registered nurse in hematology and oncology and quickly advanced to leadership roles. While serving as the Associate Director of Emergency Services at The Ohio State University Comprehensive Cancer Center, she and her team successfully launched the first fully integrated oncology emergency department in the United States. Since joining CoverMyMeds in 2017, she has successfully built and led high-performing clinical, operational, and product teams. As the Vice President of Specialty Product, she has responsibility for improving the medication access journey for patients on specialty medications. Miranda holds a Doctor of Nursing Practice and is involved in a number of community and professional organizations including the Ronald McDonald House of Central Ohio, Nationwide Children’s Hospital Foundation, and Pelotonia.

Megan Wetzel

Vice President, Product, Access & Affordability

CoverMyMeds

Megan is a seasoned leader with over a decade of experience driving innovation in healthcare technology, now serving as Vice President of Product of the Access and Affordability suite for CoverMyMeds. Since joining McKesson in 2013, Megan has held various roles in product management, dedicating her career to supporting pharmacy and pharmaceutical customers. Most recently, she served as Vice President of Product for Hub Solutions, leading strategic product development to enhance patient access and affordability, building on her prior leadership of patient affordability solutions. Through her diverse experience, Megan continues to successfully lead teams in tackling complex challenges, particularly within the pharmaceutical industry. Based in Atlanta, Georgia, Megan is recognized for her strategic vision, collaborative leadership style and commitment to creating meaningful, scalable solutions that improve health outcomes.

Ashwin Singhania

Partner/Principal of Life Science Strategy

EY-Parthenon, Ernst & Young LLP

Ashwin Singhania has over 20 years of experience in life sciences advising biopharma companies to support their strategic growth in bringing new products to market to enhance patient care. As a principal within Strategy and Transactions at EY-Parthenon, Ernst & Young LLP, Ashwin focuses on corporate and commercial strategy for biopharma across growth strategy, transaction support and operating model transformation. His career includes roles with large pharmaceutical organizations, specialty pharmaceuticals and prerevenue biotechs. He also supports private equity for investments in biopharmaceutical and biopharmaceutical services.

Fauzea Hussain

Vice President of Public Policy

McKesson

Fauzea Hussain is the Vice President of Public Policy at McKesson, where she champions public policy strategies that drive the company's mission to improve health outcomes. With a keen focus on patient-first solutions, Fauzea collaborates across the enterprise to address the diverse needs of distributors, wholesalers, community providers, health systems, pharmacies, manufacturers, technology vendors and consumers. A seasoned policy expert with over 25 years of experience, Fauzea has a proven track record in assessing the impact of state and federal policies on patient access, provider reimbursement, and the life sciences industry.

Nico Saraceno

Sr. Editor

Nutritional Outlook

Nico Saraceno is the Senior Editor of Nutritional Outlook, a publication for the dietary supplement, healthy foods, and natural products market. He also has over a half-decade of experience covering pharma’s patient access and affordability space via his time with Pharmaceutical Commerce.





Sponsors


First Name
Last Name
Email Address
Company/Organization Name
What best describes your organization?
Privacy Notice
Do Not Sell My Personal Information
© Copyright 2026 Brandlive, Inc. All rights reserved.
Already Registered? Technical Requirements System Check Port Troubleshooting